Webinars

SCLC's webinar series is integral to the technical assistance provided by the SCLC. Nationally recognized smoking cessation experts offer the latest information related to smoking cessation (including effective interventions) for the general and the behavioral health populations.

The Goals of SCLC’s Webinar Series:

  • Provide training and technical assistance to raise awareness of the many benefits smoking cessation efforts and to increase understanding of effective smoking cessation strategies.
  • Implement or enhance existing tobacco cessation services using evidence-based practices.
  • Ensure that consumers and staff have access to smoking cessation services and supports to promote health and wellness.
  • Establish partnerships between behavioral health and nicotine cessation organizations to increase available tobacco cessation resources in communities. 

SCLC has over 55 webinars covering the latest topics on tobacco addiction and recovery.

Upcoming Webinars

Reducing Tobacco Use among African Americans and Youth: What's Menthol Got To Do With It?

Speakers

Phillip Gardiner, Dr. PH.

Policy and Regulatory Sciences Program Officer Tobacco Related Disease Research Program University of California Office of the President

Dr. Gardiner received his Doctorate in Behavioral Sciences from the University of California at Berkeley, where he focused on Youth Violence as a public health issue. Throughout his research career, Dr. Gardiner has maintained his community activism to address racial disparities in health, through writing, organizing, evaluating and public speaking. For the past 15 years, Dr. Gardiner has lectured around the country on African American health disparities generally and menthol smoking in the Black Community, particularly. Currently, Dr. Gardiner is the Policy and Regulatory Sciences Program Officer for the Tobacco Related Disease Research Program (TRDRP), University of California Office of the President, where he oversees the scientific inquiry associated with e-cigarettes. Dr. Gardiner speaks regularly around the country on banning menthol cigarettes and regulating electronic cigarettes. In the fall of 2013, Dr. Gardiner led an international webcast on e-cigarettes, with over 700 participating from across the country and around the world (The Vapor this Time). Also in the Fall of 2013, he worked with the Chicago Department of Health to help pass a local ordinance, the first of its kind in the country, to restrict the selling of menthol and other flavored tobacco products within 500 feet of city schools. By 2015, the cities of Baltimore and Minneapolis began discussions on regulating menthol. This past Fall, Berkeley California banned the sale of menthol and other flavored tobacco products around its schools. Additionally, throughout 2014 and 2015, Dr. Gardiner was instrumental in shaping many local e-cigarette regulatory policies around the country, including the cities of Richmond, Chicago, Los Angeles and San Francisco.

Dr. Gardiner is also an adjunct faculty member at Touro University in Vallejo, a graduate medical college, where he teaches a course on Health Disparities. Additionally, Dr. Gardiner is the leader of an independent consultation firm, Gardiner & Associates, whose main evaluation work has centered on health disparities. And lastly, Dr. Gardiner is Co-Chair of the African American Tobacco Control Leadership Council (AATCLC), a group of Black professionals dedicated to fighting the scourge of tobacco impacting the African American community in California and Nationally.

Webinar Objectives

  • Explain the African Americanization of menthol cigarettes in the United States

  • Understand Youth use of menthol cigarettes

  • Identify the chemical impact of menthol in cigarette smoke and e-cigarette aerosol

  • Describe the fightback against menthol tobacco products

Beyond the Basics: Pharmacotherapy for Smoking Cessation

Speakers

Robin L. Corelli, PharmD

Robin L. Corelli, Pharm.D. is a pharmacist and Professor in the School of Pharmacy at UCSF. For the past 15 years, Dr. Corelli’s primary research and practice related focus has been in the area of smoking cessation. During this time, she has been actively involved as a smoking cessation provider in the UCSF Fontana Tobacco Treatment Center and she has trained more than 4,000 health care providers (students and licensed clinicians in medicine, nursing, pharmacy, dentistry and respiratory therapy) to provide cessation assistance to their patients who smoke.

Karen S. Hudmon, DrPH, MS, RPh

Professor of Pharmacy Practice, Department of Pharmacy Practice, Purdue University College of Pharmacy and Clinical Professor at the School of Pharmacy, at the University of California, San Francisco

Karen S. Hudmon, DrPH, MS, RPh, is Professor of Pharmacy Practice at Purdue University College of Pharmacy and Clinical Professor at the UCSF School of Pharmacy. She is a licensed pharmacist and a cancer prevention researcher with more than 20 years of tobacco research experience, focusing on both prevention and treatment aspects of tobacco control. As an educator, she has provided tobacco cessation training to more than 15,000 health professionals (students and licensed clinicians) and has been a long-time activist for eliminating tobacco sales in pharmacies.

Webinar Objectives

  • Identify patients who are candidates for combination therapy and, after consideration of patient-specific factors, design a treatment regimen (drugs, dosages, routes, and duration of therapy).

  • Identify patients who are candidates for high-dose pharmacotherapy and recommend a treatment regimen (drug, dose, route, and duration of therapy).

  • Identify patients who are candidates for extended-duration pharmacotherapy and recommend a treatment plan (drug, dose, route and duration of therapy).

  • Determine situations for which use of nicotine replacement therapy prior to the quit date might be beneficial and recommend a treatment regimen (drug, dose, route, and duration of therapy)